Stock AWH ASPIRA WOMEN'S HEALTH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
3.213 USD -0.21% Intraday chart for Aspira Women's Health Inc. -2.04% -21.25%
May. 02 Aspira Women's Health Inc. Enhances Its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of Ovawatch CI
Apr. 26 Aspira Women's Health Inc. Announces Minh Merchant Resigns as General Counsel, Chief Compliance Officer, and Corporate Secretary, Effective May 6, 2024 CI

Evolution of the average Target Price on Aspira Women's Health Inc.

Price target over the last 5 years

History of analyst recommendation changes

9985798c12aef04f3cf9b81.9t5SPeZQ_n7jGlN8YszcL_1tVZ-LOKf3H3i1dJNdbmQ.z-gNUrA1tQvaSgUXDYeQGYQnO6jBdsS6eCn5EsAeXyu16CZ-0ySvDZBcCg~726edf5dc65b8e7cf649c59780690512

Analyst Recommendations on Aspira Women's Health Inc.

Cantor Fitzgerald Trims Price Target on Aspira Women's Health to $3.30 From $4, Maintains Neutral Rating MT
Alliance Global Starts Aspira Women's Health With Buy Rating, $5.60 Price Target MT
Cantor Fitzgerald Increases Price Target on Aspira Women's Health to $4.50 From $2, Maintains Neutral Rating MT
Cantor Fitzgerald Downgrades Aspira Women's Health to Neutral From Overweight, Adjusts Price Target to $2 From $3 MT
Wall Street Stabilizes Pre-Bell After Slump Fueled by Rate Hike Concerns MT
ASPIRA WOMEN HEALTH : Truist Securities Starts Aspira Women's Health at Buy With $12 Price Target MT
ASPIRA WOMEN HEALTH : Cantor Fitzgerald Starts Aspira Women's Health at Overweight With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
3.213 USD
Average target price
3.3 USD
Spread / Average Target
+2.70%
High Price Target
3.3 USD
Spread / Highest target
+2.70%
Low Price Target
3.3 USD
Spread / Lowest Target
+2.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aspira Women's Health Inc.

Cantor Fitzgerald
Alliance Global Partners
Truist Securities

Ratings for Aspira Women's Health Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AWH Stock
  4. Consensus Aspira Women's Health Inc.